Protara Therapeutics (TARA) Equity Ratio (2016 - 2026)
Protara Therapeutics' Equity Ratio history spans 14 years, with the latest figure at 0.94 for Q1 2026.
- Quarterly Equity Ratio changed 0.42% to 0.94 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.94 through Mar 2026, changed 0.42% year-over-year, with the annual reading at 0.94 for FY2025, 1.8% up from the prior year.
- Equity Ratio came in at 0.94 for Q1 2026, up from 0.94 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.94 in Q1 2026 to a low of 0.86 in Q1 2024.
- The 5-year median for Equity Ratio is 0.91 (2025), against an average of 0.91.
- Year-over-year, Equity Ratio dropped 7.13% in 2023 and then rose 9.68% in 2025.
- Protara Therapeutics' Equity Ratio stood at 0.9 in 2022, then dropped by 3.97% to 0.87 in 2023, then rose by 6.44% to 0.92 in 2024, then grew by 1.8% to 0.94 in 2025, then rose by 0.69% to 0.94 in 2026.
- Per Business Quant, the three most recent readings for TARA's Equity Ratio are 0.94 (Q1 2026), 0.94 (Q4 2025), and 0.91 (Q3 2025).